Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiple Sclerosis: The Role of Mitochondrial Dysfunction in Insulin Resistance

NCT03052595 is registered in ClinicalTrials.gov with Slovak Academy of Sciences as lead sponsor.

NCT NCT03052595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03052595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiple Sclerosis: The Role of Mitochondrial Dysfunction in Insulin Resistance
Lead sponsor
Slovak Academy of Sciences
Phase
Observational
Overall status
Completed
Start date
February 1, 2017
Completion date
March 31, 2023
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mitochondrial alteration, multiple sclerosis